Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement

BackgroundMalignancies represent 15–50% of total causes of pericardial effusions (PE). Routine analyses recommended to be performed on pericardial fluid include general chemistry, cytology, polymerase chain reaction, and microbiological cultures. Multicolor flow cytometry (FC) is a laboratory test t...

Full description

Bibliographic Details
Main Authors: Luigi Cappannoli, Massimo Imazio, Stefan Hohaus, Gianluigi Saponara, Domenico D’Amario, Silvia Bellesi, Elena Maiolo, Marcello Viscovo, Federica Fatone, Eleonora Alma, Francesco D’Alò, Filippo Crea, Tommaso Sanna
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1000259/full
_version_ 1828094647038115840
author Luigi Cappannoli
Luigi Cappannoli
Massimo Imazio
Stefan Hohaus
Stefan Hohaus
Gianluigi Saponara
Domenico D’Amario
Domenico D’Amario
Silvia Bellesi
Elena Maiolo
Marcello Viscovo
Federica Fatone
Eleonora Alma
Francesco D’Alò
Francesco D’Alò
Filippo Crea
Filippo Crea
Tommaso Sanna
Tommaso Sanna
author_facet Luigi Cappannoli
Luigi Cappannoli
Massimo Imazio
Stefan Hohaus
Stefan Hohaus
Gianluigi Saponara
Domenico D’Amario
Domenico D’Amario
Silvia Bellesi
Elena Maiolo
Marcello Viscovo
Federica Fatone
Eleonora Alma
Francesco D’Alò
Francesco D’Alò
Filippo Crea
Filippo Crea
Tommaso Sanna
Tommaso Sanna
author_sort Luigi Cappannoli
collection DOAJ
description BackgroundMalignancies represent 15–50% of total causes of pericardial effusions (PE). Routine analyses recommended to be performed on pericardial fluid include general chemistry, cytology, polymerase chain reaction, and microbiological cultures. Multicolor flow cytometry (FC) is a laboratory test that already proved to be useful in the detection of lymphoproliferative and metastatic malignancies in pleural and peritoneal effusions, but current guidelines do not mention its use on PE to reach a diagnosis.MethodsOur institutional protocol foresees to routinely perform a multicolor FC analysis on pericardial fluid samples obtained by pericardiocentesis, in addition to other guidelines-recommended analyses. A sample of 15–30 ml is analyzed using a lyse and wash staining method using combination panels of antibodies, allowing to detect specific cellular subpopulations, analyzing tens to hundreds of thousands of cells in few seconds. The present manuscript aims to report our single-center experience with this diagnostic tool in patients presenting with PE requiring pericardiocentesis.ResultsRoutine use of multicolor FC on pericardial fluid samples in our institution allowed to reach a definite diagnosis of cardiac lymphomas in two patients presenting with otherwise unexplained severe PE. This resulted in immediate start of combined immunotherapy, with patients’ clinical improvement. At 6 months follow-up both patients are alive and presented a complete disease regression.ConclusionPreliminary evidence from routine use of multicolor FC on PE support that this is a promising tool to reach a rapid diagnosis of hematological malignancies with heart involvement, leading to a prompt initiation of targeted therapies.
first_indexed 2024-04-11T07:01:13Z
format Article
id doaj.art-7b52700064624a6da95979293d1fb049
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T07:01:13Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-7b52700064624a6da95979293d1fb0492022-12-22T04:38:42ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-11-01910.3389/fcvm.2022.10002591000259Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvementLuigi Cappannoli0Luigi Cappannoli1Massimo Imazio2Stefan Hohaus3Stefan Hohaus4Gianluigi Saponara5Domenico D’Amario6Domenico D’Amario7Silvia Bellesi8Elena Maiolo9Marcello Viscovo10Federica Fatone11Eleonora Alma12Francesco D’Alò13Francesco D’Alò14Filippo Crea15Filippo Crea16Tommaso Sanna17Tommaso Sanna18Department of Cardiovascular Sciences, Catholic University of the Sacred Heart (UCSC), Rome, ItalyDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyCardiology, Department of Cardiothoracic, University Hospital “Santa Maria della Misericordia”, ASUFC, Udine, ItalyDepartment of Imaging Diagnostic, Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Rome, ItalyDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Cardiovascular Sciences, Catholic University of the Sacred Heart (UCSC), Rome, ItalyDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Imaging Diagnostic, Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Imaging Diagnostic, Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Imaging Diagnostic, Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Rome, ItalyDepartment of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Rome, ItalyDepartment of Imaging Diagnostic, Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Rome, ItalyDepartment of Cardiovascular Sciences, Catholic University of the Sacred Heart (UCSC), Rome, ItalyDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyDepartment of Cardiovascular Sciences, Catholic University of the Sacred Heart (UCSC), Rome, ItalyDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyBackgroundMalignancies represent 15–50% of total causes of pericardial effusions (PE). Routine analyses recommended to be performed on pericardial fluid include general chemistry, cytology, polymerase chain reaction, and microbiological cultures. Multicolor flow cytometry (FC) is a laboratory test that already proved to be useful in the detection of lymphoproliferative and metastatic malignancies in pleural and peritoneal effusions, but current guidelines do not mention its use on PE to reach a diagnosis.MethodsOur institutional protocol foresees to routinely perform a multicolor FC analysis on pericardial fluid samples obtained by pericardiocentesis, in addition to other guidelines-recommended analyses. A sample of 15–30 ml is analyzed using a lyse and wash staining method using combination panels of antibodies, allowing to detect specific cellular subpopulations, analyzing tens to hundreds of thousands of cells in few seconds. The present manuscript aims to report our single-center experience with this diagnostic tool in patients presenting with PE requiring pericardiocentesis.ResultsRoutine use of multicolor FC on pericardial fluid samples in our institution allowed to reach a definite diagnosis of cardiac lymphomas in two patients presenting with otherwise unexplained severe PE. This resulted in immediate start of combined immunotherapy, with patients’ clinical improvement. At 6 months follow-up both patients are alive and presented a complete disease regression.ConclusionPreliminary evidence from routine use of multicolor FC on PE support that this is a promising tool to reach a rapid diagnosis of hematological malignancies with heart involvement, leading to a prompt initiation of targeted therapies.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1000259/fullpericardial effusionflow cytometry—methodsmalignanciesheart failurecardiac lymphomaguidelines
spellingShingle Luigi Cappannoli
Luigi Cappannoli
Massimo Imazio
Stefan Hohaus
Stefan Hohaus
Gianluigi Saponara
Domenico D’Amario
Domenico D’Amario
Silvia Bellesi
Elena Maiolo
Marcello Viscovo
Federica Fatone
Eleonora Alma
Francesco D’Alò
Francesco D’Alò
Filippo Crea
Filippo Crea
Tommaso Sanna
Tommaso Sanna
Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
Frontiers in Cardiovascular Medicine
pericardial effusion
flow cytometry—methods
malignancies
heart failure
cardiac lymphoma
guidelines
title Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
title_full Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
title_fullStr Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
title_full_unstemmed Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
title_short Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
title_sort multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement
topic pericardial effusion
flow cytometry—methods
malignancies
heart failure
cardiac lymphoma
guidelines
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1000259/full
work_keys_str_mv AT luigicappannoli multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT luigicappannoli multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT massimoimazio multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT stefanhohaus multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT stefanhohaus multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT gianluigisaponara multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT domenicodamario multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT domenicodamario multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT silviabellesi multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT elenamaiolo multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT marcelloviscovo multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT federicafatone multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT eleonoraalma multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT francescodalo multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT francescodalo multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT filippocrea multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT filippocrea multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT tommasosanna multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement
AT tommasosanna multicolorflowcytometryonpericardialeffusionforapromptdiagnosisandtreatmentofhematologicalmalignancieswithheartinvolvement